Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease
Armillei M, Lomakin I, Del Rosso J, Grada A, Bunick C. Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease. Antibiotics 2024, 13: 270. PMID: 38534705, PMCID: PMC10967556, DOI: 10.3390/antibiotics13030270.Peer-Reviewed Original ResearchSoft tissue infectionsTetracycline class antibioticsTreatment of dermatological diseasesMechanism of protein synthesis inhibitionClindamycin useStaphylococcal infectionsTissue infectionsClinical presentationAnti-inflammatory propertiesHidradenitis suppurativaEffective antibioticsTreatment optionsClindamycinClinical evidenceAcne vulgarisClinical basisProtein synthesis inhibitionDermatological indicationsAmeliorate inflammationAntibiotic resistanceDermatology practiceBacterial ribosomeDermatological diseasesClass antibioticsLesion formationRethinking Hidradenitis Suppurativa Management: Insights into Bacterial Interactions and Treatment Evolution
Huynh F, Damiani G, Bunick C. Rethinking Hidradenitis Suppurativa Management: Insights into Bacterial Interactions and Treatment Evolution. Antibiotics 2024, 13: 268. PMID: 38534703, PMCID: PMC10967558, DOI: 10.3390/antibiotics13030268.Peer-Reviewed Original ResearchHidradenitis suppurativaChronic inflammatory dermatologic conditionInflammatory dermatological conditionsAnti-inflammatory approachesQuality of life of patientsRemittive therapyRecurrent nodulesCutaneous dysbiosisSinus tractLife of patientsInframammary regionAcne inversaPurulent abscessesTreatment approachesTreatment evolutionDermatological conditionsTherapeutic innovationsDisease-modifyingMulti-factorial